济民制药 (603222.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(济民制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2019年一季报2018年年报2018年三季报2018年中报2018年一季报2017年年报2017年三季报2017年中报2017年一季报
主要指标:
 营业收入(元) 192,878,575.35697,831,631.05539,380,840.18349,208,852.93164,295,406.81602,898,708.81450,540,814.67284,334,053.62133,224,729.02
 营业利润(元) 18,098,307.8755,114,712.1363,551,529.5047,415,590.1316,756,740.1674,121,453.5754,580,315.6027,824,470.3911,496,853.39
 利润总额(元) 18,042,334.7552,835,456.3862,349,002.7146,588,781.3816,341,974.7070,999,654.9351,966,597.5826,464,017.7411,668,276.53
 净利润(元) 13,596,802.1243,043,269.6548,841,129.9534,647,130.5211,794,753.7555,894,317.9841,653,148.8920,869,280.298,922,564.27
 归属于母公司股东的净利润(元) 11,261,381.6632,062,818.7036,912,156.4228,415,679.8811,213,798.9252,884,359.8339,951,863.6019,997,060.308,666,820.20
盈利能力:
 销售毛利率(%) 42.1741.5244.8745.2743.7045.0044.5743.8942.63
 销售净利率(%) 7.056.179.069.927.189.279.257.346.70
 净资产收益率(%) 1.394.004.633.631.43----
 总资产报酬率ROA(%) 1.353.954.553.361.49----
 投入资本回报率ROIC(%) 0.682.392.632.220.965.514.352.200.98
营运能力:
 存货周转率(次) 1.254.173.022.010.97----
 应收账款周转率(次) 0.934.102.631.870.92----
 总资产周转率(次) 0.100.380.320.210.12----
偿债能力:
 资产负债率(%) 50.8150.7447.1747.3339.7141.0632.6932.7930.58
 股东权益比率(%) 38.0838.1140.8840.8650.9050.3858.1858.2762.36
 已获利息倍数(倍) 3.523.605.616.484.636.006.425.345.24
 流动比率 0.950.870.920.911.110.971.651.852.35
 速动比率 0.800.720.700.720.840.751.231.411.81
发展能力:
 营业收入增长率(%) 17.4015.7519.7222.8223.3233.8636.9536.7229.90
 营业利润增长率(%) 8.01-25.6416.4470.4138.7157.4377.7874.3237.40
 税后利润增长率(%) 0.42-39.37-7.6142.1029.3929.3256.5056.0127.41
 净资产增长率(%) 1.902.054.445.895.875.625.985.114.39
 总资产增长率(%) 36.2134.9248.6651.0129.7070.7450.5252.2441.89

前瞻产业研究院